⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SGMT News
Sagimet Biosciences Inc. Series A Common Stock
Form 8-K
sec.gov
SGMT
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
globenewswire.com
SGMT
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Provides Strategic and Corporate Updates
globenewswire.com
SGMT
Form 8-K
sec.gov
SGMT
OMER
AMGN
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
globenewswire.com
SGMT
OMER
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
SGMT
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
globenewswire.com
SGMT